NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, this week announced a collaboration for the development of new analysis tools for data generated on NanoString’s nCounter® Analysis System. The new analysis functionality is built into ROSALIND™ , OnRamp’s cloud-based analysis suite that facilitates data visualization, exploration and collaboration. The companies are releasing these new capabilities through Early Access and immediately offering it to COVID-19 researchers performing critical host response studies on the nCounter platform.
“ROSALIND offers powerful data analysis capabilities and a unique ability to facilitate collaboration amongst researchers,” said Joe Beechem, Chief Scientific Offer and SVP of R&D for NanoString. "This partnership represents a shared vision of accelerating research through making gene expression analysis simple and broadly accessible.”
ROSALIND is a cloud platform that connects researchers to perform differential expression and ...
